Resistance of Candida species to antifungal agents used in the treatment of onychomycosis: A review of current problems

British Journal of Dermatology, Supplement

Volumn 141, Issue 56, 1999, Pages 33-35

  Evans, E G V ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; FLUCONAZOLE; ITRACONAZOLE; TERBINAFINE;

ARTICLE; CANDIDA; CANDIDIASIS; CROSS RESISTANCE; HUMAN; MYCOSIS; NAIL INFECTION; NONHUMAN; ONYCHOMYCOSIS; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0032739039     PISSN: 0366077X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.1999.00012.x     Document Type: Article

References (5)

1. Evans EGV, Sigurgeirsson B. Double blind, randomised study of continuous terbinafine compared with intermittent itraconazole in treatment of toenail onychomycosis. Br Med J 1999; 318: 1031-5.
2. Vanden Bossche H, Dromer F, Improvisi I, Lozano-Chiu M, et al. Antifungal drug resistance in pathogenic fungi. Med Mycol 1998; 36 (Suppl. 1): 119-28.
3. van 't Wout JW. Fluconazole treatment of candidal infections caused by non-albicans Candida species. Eur J Clin Microbiol Infect Dis 1996; 15: 238-42.
4. Boken DJ, Swindells S, Rinaldi MG. Fluconazole-resistant Candida albicans. Clin Infect Dis 1993; 17: 1018-21.
5. Johnson EM, Davey KG, Szekely A, Warnock DW. Itraconazole susceptibilities of fluconazole susceptible and resistant isolates of five Candida species. J Antimicrob Chemother 1995; 36: 787-93.